Ipsos Healthcare adds Hidradenitis Suppurativa (HS) to Global Therapy Monitor Portfolio
Ipsos Healthcare, the global healthcare division of Ipsos, has launched the Hidradenitis Suppurativa (HS) Therapy Monitor in the EU5. The HS Monitor, part of Ipsos’ Autoimmune Real World Evidence portfolio, launched in the EU5 in Q2 of 2017, with plans to extend to other markets.
Ipsos Launches Ipsos Connect for Brand Communication, Advertising and Media Services
Ipsos is pleased to announce the launch of Ipsos Connect, a global specialised business to coordinate Ipsos’ services in the domains of Brand Communication, Advertising and Media. Ipsos Connect amalgamates the legacy brands of Ipsos ASI and Ipsos MediaCT.
How Concerned Are You About the Ebola Virus?
77% of global citizens concerned that Ebola virus may be transmitted to their country. With 88% awareness of Ebola virus outbreak, 57% say their own health, government and other officials are taking enough precautions and preparations to ensure virus doesn’t come into their country but 43% don’t believe it to be so.